Possible involvement of antitumor immunity in the eradication of Colon 26 induced by low-voltage electrochemotherapy with bleomycin

Surgery Today

Volumn 33, Issue 1, 2003, Pages 39-44

  Miyazaki, Shinichi ^a   Gunji, Yoshio ^a   Matsubara, Hisahiro ^a   Shimada, Hideaki ^a   Uesato, Masaya ^a   Suzuki, Takao ^a   Kouzu, Teruo ^a   Ochiai, Takenori ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antitumor immunity; Bleomycin; Colon carcinoma; Low voltage electroporation

Indexed keywords

BLEOMYCIN;

ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER SURVIVAL; CELLULAR IMMUNITY; COLON CANCER; CONTROLLED STUDY; ELECTRIC FIELD; ELECTRIC POTENTIAL; ELECTROCHEMOTHERAPY; ELECTROPORATION; FEMALE; INOCULATION; MOUSE; MOUSE STRAIN; NONHUMAN; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR VOLUME;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BLEOMYCIN; COLONIC NEOPLASMS; ELECTRIC STIMULATION THERAPY; FEMALE; IMMUNITY, CELLULAR; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; T-LYMPHOCYTES;

EID: 0037285802     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005950300006     Document Type: Article

References (22)

1. Mir LM, Orlowski S. The basis of electrochemotherapy. In: Jaroszeski MJ, Heller R, Gilbert R, editors. Electrochemotherapy, electrogenetherapy, and transdermal drug delivery. Electrically mediated delivery of molecules to cells. Totowa: Humana; 2000. p. 99-117.
2. Sersa G. Electrochemotherapy: animal model work review. In: Jaroszeski MJ, Heller R, Gilbert T, editors. Electrochemotherapy, electrogenetherapy, and transdermal drug delivery. Electrically mediated delivery of molecules to cells. Totowa: Humana; 2000. p. 119-36.
3. Heller R, Gilbert R, Jaroszeski MJ. Clinical trials of solid tumors using electrochemotherapy. In: Jaroszeski MJ, Heller R, Gilbert R, editors. Electrochemotherapy, electrogenetherapy, and transdermal drug delivery. Electrically mediated delivery of molecules to cells. Totowa: Humana; 2000. p. 137-56.
4. 111In-bleomycin complex in normal and glioma bearing rats after in vivo electropermeabilization using exponential high-voltage pulses. Bioelectrochem Bioenerget 1998;46:241-8.
5. Belehradek J Jr, Orlowski S, Ramirez LH, Pron G, Poddevin B, Mir LM. Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochim Biophys Acta 1994;1190:155-3.
6. Mir LM, Orlowski S, Poddevin B, Belehradek J Jr. Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. Eur Cytokine Netw 1992;3:331-4.
7. Mir LM, Roth C, Orlowski S, Quintin-Colonna F, Fradelizi D, Belehradek J Jr, et al. Systemic antitumor effects of electrochemotherapy combined with histoincompatible cell secreting interleukin-2. J Immunother 1995;17:30-8.
8. Kuriyama S, Mitoro A, Tsujinoue H, Toyokawa Y, Nakatani T, Yoshiji H, et al. Electrochemotherapy can eradicate established colorectal carcinoma and leave a systemic protective memory in mice. Int J Oncol 2000;16:979-85.
9. Jaroszeski MJ, Coppola D, Pottnger C, Benson K, Gilbert RA, Heller R. Treatment of hepatocellular carcinoma in a rat model using electrochemotherapy. Eur J Cancer 2001;37:422-30.
10. Horiuchi A, Nakaido T, Mitsushita J, Toki T, Konishi I, Fujii S. Enhancement of antitumor effect of bleomycin by low-voltage in vivo electroporation: a study of human uterine leiomyosarcomas in nude mice. Int J Cancer 2000;88:640-4.
11. Gunji Y, Tagawa M, Matsubara H, Takenaga K, Shimada H, Kondo F, et al. Murine colon carcinoma cells engineered to produce human interleukin-2 induce tumor-specific anti-tumor response. Int J Cancer 1996;66:135-9.
12. Auerbach R, Morrissey LW, Sidky YA. Regional differences in the incidence and growth of mouse tumors following intradermal or subcutaneous inoculation. Cancer Res 1978;38:1739-44.
13. Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek J Jr, Mir LM. Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 1993;72:3694-700.
14. Domenge C, Orlowski S, Luboinski B, De Baere T, Schwaab G, Belehradek J Jr, et al. Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer 1996;77:956-63.
15. Heller R, Jaroszeski MJ, Reintgen DS, Puleo CA, Deconti RC, Gilbert RA, et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 1998;83:148-57.
16. Mir LM, Glass LF, Sersa G, Teissie J, Domenge C, Miklavcic D, et al. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 1998;77:2336-42.
17. Sambrook J, Fritsch EF, Maniatis T. DNA transfection by electroporation. In: Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1989. p. 16.54-5.
18. Muramatsu T, Nakamura A, Park HM. In vivo electroporation: a powerful and convenient means of nonviral gene transfer to tissues of living animals (Review). Int J Mol Med 1998;1:55-62.
19. Mir LM, Tounekti O, Orlowski S. Bleomycin: revival of an old drug. Gen Pharmacol 1996;5:745-8.
20. Byrnes RW, Templin J, Sem D, Lyman S, Petering DH. Intracellular DNA strand scission and growth inhibition of Ehrlich ascites tumor cells by bleomycins. Cancer Res 1990;50:5275-86.
21. Mir LM, Orlowski S, Belehradek J Jr, Paoletti C. Electrochemotherapy potentiation of antitumor effect of bleomycin by local electric pulses. Eur J Cancer 1991;27:68-72.
22. Belehradek J Jr, Orlowski S, Poddevin B, Paoletti C, Mir LM. Electrochemotherapy of spontaneous mammary tumours in mice. Eur J Cancer 1991;27:73-6.